Achillion Pharmaceuticals, Inc.
(NASDAQ : ACHN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
1.11%302.721.4%$587.49m
AMGNAmgen, Inc.
0.18%233.831.3%$518.85m
GILDGilead Sciences, Inc.
1.85%67.151.0%$370.33m
REGNRegeneron Pharmaceuticals, Inc.
0.97%371.922.6%$303.41m
VRTXVertex Pharmaceuticals, Inc.
-0.15%222.741.9%$267.72m
ILMNIllumina, Inc.
2.05%326.363.5%$237.86m
ARWRArrowhead Pharmaceuticals, Inc.
2.93%67.4512.0%$192.70m
EXASEXACT Sciences Corp.
3.46%86.5124.0%$184.63m
CLVSClovis Oncology, Inc.
12.42%9.9614.7%$182.25m
ALXNAlexion Pharmaceuticals, Inc.
5.40%113.222.0%$179.31m
SRPTSarepta Therapeutics, Inc.
-0.20%109.7514.6%$148.54m
AAgilent Technologies, Inc.
0.71%82.111.6%$141.49m
BMRNBioMarin Pharmaceutical, Inc.
0.77%80.704.3%$131.10m
SGENSeattle Genetics, Inc.
0.34%117.566.1%$128.32m
NBIXNeurocrine Biosciences, Inc.
-0.52%115.885.0%$126.90m

Company Profile

Achillion Pharmaceuticals, Inc. engages in the discovery and development of small molecule drug therapies for immune system disorders. It offers its propriety platform of potent and specific complement factor D inhibitors for AP-mediated diseases. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.